SynthesisFrontiers in oncology2020

Evaluation of the Efficacy and Safety of PARP Inhibitors in Advanced-Stage Epithelial Ovarian Cancer.

Yifan Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.